As the Lipid Technology segment of the Croda Health Care business, part of the Life Science sector of Croda Inc., Avanti is primarily focused on developing innovative lipid-based products of unparalleled purity to address specific medical challenges that are not resolved by current technology or drug products. For over 30 years, Avanti has been working with the pharmaceutical and diagnostic industry to provide solutions that save or improve lives. Over the past decade, we have concentrated on developing the lipid components used in Lipid Nanoparticle (LNP) delivery technology to solve the stability and delivery issues associated with mRNA-based vaccines and therapeutics, as well as gene editing technology. Avanti’s clients include Pharmaceutical Industries, Nutraceutical Industries and Lipid Researchers.